• My Dashboard My Education Find an Ophthalmologist
  • Home
  • Coronavirus
  • For Ophthalmologists
    • Meetings
      • AAO 2022
        • Meeting Information
          • Past and Future Meetings
          • Mobile Meeting Guide
          • Contact Information
          • Annual Meeting News
          • Health and Safety
          • Policies and Disclaimers
        • Program
          • Program Highlights
          • Subspecialty Day
          • Virtual Meeting
          • Program Committees
          • CME
          • Meeting Archives
        • Expo
        • Registration
        • Hotels & Travel
          • Hotel Reservation Information
          • Chicago
          • International Attendees
          • Hotel Meeting Space
        • Presenter Central
          • Presenter Central
          • Abstract Selection Process
          • Submission Policies
          • Subject Classification/Topics
          • Instruction Courses and Skills Transfer Labs
          • Papers and Posters
          • Videos
          • Grand Rounds Symposium
          • Program Participant and Faculty Guidelines
          • Faculty Development Program
        • Exhibitors
          • Exhibitor Central
          • Exhibitor Portal Information
          • Exhibitor Prospectus
          • New Exhibiting Companies
          • Exhibitor Resources
          • International Exhibitors
          • Promotional Opportunities
          • Exhibitor Hotel Reservations
      • Mid-Year Forum
        • Registration and Travel
        • Congressional Advocacy Day
        • Advocacy Ambassador Program
        • Program
        • Schedule
        • Sponsored Attendees
        • News
      • Codequest
        • Codequest Instructors
        • Claim Codequest CME or CEU Credit
      • Eyecelerator
    • Clinical Education
      • COVID-19
      • Education
        • Browse All Education
        • Courses
        • Cases
        • Learning Plans
        • Interactive
        • Focal Points
        • Wills Eye Manual
        • Disease Reviews
        • Clinical Webinars
        • Diagnose This
        • Self-Assessments
        • Educational Centers
          • Glaucoma Education Center
          • Pediatric Ophthalmology Education Center
          • Laser Surgery Education Center
          • Myopia Resources
          • Oculofacial Plastic Surgery Center
          • Redmond Ethics Center
      • Journals
      • Guidelines
        • Browse All Practice Guidelines
        • Preferred Practice Patterns
        • Clinical Statements
        • Compendium Guidelines
        • Complementary Therapy Assessments
        • Medical Information Technology
        • Ophthalmic Technology Assessments
        • Patient Safety Statements
        • Choosing Wisely
        • Low Vision
        • Eye Care for Older Adults
        • Eye Disease Statistics
        • About the Hoskins Center
      • Video and Image Library
        • Browse All Videos
        • Clinical and Surgical Videos
        • Presentations and Lectures
        • 1-Minute Videos
        • Master Class Videos
        • Basic Skills Videos
        • Interviews
        • Images
        • Submit an Image
        • Submit a Video
      • Podcasts
        • Browse All Audio and Podcasts
        • Experts InSight
        • Ophthalmology Journal
      • News
        • Browse All Clinical News
        • Editors' Choice
        • Headlines
        • Current Insight
      • CME Central
        • Browse All CME Activities
        • Claim CME Credit and View Transcript
        • CME Planning Resources
        • Complete Your Financial Disclosure
        • Joint Sponsorship Portal
        • LEO Continuing Education Recognition Award
        • Safe ER/LA Opioid Prescribing
        • Check Your Industry Payment Records
      • MOC
      • Resident Education
        • Resident Education Home
        • Browse All Resident Content
          • Courses
          • Flashcards
          • Interactive Cases and Simulations
          • Videos
          • Webinars
        • OKAP and Board Exam Resources
          • OKAP Exam
          • Board Prep Resources
          • OKAP and Board Review Presentations
          • Study Flashcards
        • Cataract Master
        • Diversity and Inclusion Education
        • News and Advice from YO Info
        • Pediatric Ophthalmology Education Center
        • PGY-1 and PGY-2 Resources
        • Simulation in Resident Education
    • Membership
      • Join
      • Renew
      • Current Member
      • Volunteer
      • Physician Wellness
      • Member Directory
      • Member Obituaries
      • AAOE Membership
    • Advocacy
      • Advocacy News
      • Get Involved
        • Ways to Give
        • How to Get Involved
        • Congressional Advocacy
        • Support the Academy's Agenda
        • Research Legislation
        • Find Your Legislators
        • I Am an Advocate
        • Advocacy at Home
        • Advocate Tools
        • Best Practices for Advocating at Home
        • Social Media Toolkit
        • Letter to Editor
        • Town Hall Guide
        • Guide to Engaging With New Lawmakers
        • Resources
        • Attending a Political Fundraiser
      • OPHTHPAC
        • About Us
        • Join OPHTHPAC
        • OPHTHPAC Blog
      • Surgical Scope Fund
        • Support Surgery By Surgeons
        • Surgery By Surgeons Blog
    • Publications
      • EyeNet Magazine
        • Latest Issue
        • Archive
        • Subscribe
        • Advertise
        • Write For Us
        • Corporate Lunches
        • Contact
        • MIPS 2022
      • Focal Points
      • Ophthalmology
      • Ophthalmology Glaucoma
      • Ophthalmology Retina
      • YO Info
      • Scope
    • Subspecialties
      • Cataract/Anterior Segment
      • Comprehensive Ophthalmology
      • Cornea/External Disease
      • Glaucoma
      • Neuro-Ophthalmology/Orbit
      • Ocular Pathology/Oncology
      • Oculoplastics/Orbit
      • Pediatric Ophthalmology/Strabismus
      • Refractive Management/Intervention
      • Retina/Vitreous
      • Uveitis
    • IRIS Registry
      • About
      • Using the Registry
        • User Guide
        • Medicare Reporting
        • Maintenance of Certification
        • Non-EHR Reporting
      • Sign Up
        • Application Process
        • Why Participate
        • Once You've Applied: Getting Started
        • What Practices Are Saying About the Registry
      • Requirements
        • EHR Systems
        • Data & Technical Needs
      • Research
      • Registry Dashboard
      • News
      • Medicare & MIPS
    • Medicare Information
    • Diversity, Equity, and Inclusion
  • For Practice Management
    • Managing Your Practice
      • Managing Your Practice Topics
      • Coronavirus Resources
      • Reopening & Recovery
      • Practice Forms Library
      • Practice Management News and Advice
      • AAOE-Talk
      • Video Library
      • Ophthalmology Job Center
      • Benchmarking and Salary Tools
      • Academy Consultations
      • Consultant Directory
    • Coding
      • Coding Topics
      • Codequest Events
      • Ask the Coding Experts
      • Coding Updates and Resources
      • Coding for Injectable Drugs
      • EM Documentation
      • ICD-10-CM
      • Ophthalmic Coding Specialist (OCS) Exam
      • Retina
      • Savvy Coder
    • Webinars and Events
      • Annual Meeting
      • Codequest Courses
      • Mid-Year Forum
      • Webinar Recordings
    • IRIS Registry
      • Merit-Based Incentive Payment
    • Medicare and MIPS
      • MIPS
        • Quality
        • Promoting Interoperability
        • Improvement Activities
        • Cost
        • Avoid a Penalty
      • Resources
      • Medicare Participation Options
      • Medicare Advantage Plans
      • New Medicare Card
      • Provider Enrollment, Chain and Ownership System (PECOS)
    • Regulatory Compliance
      • HIPPA Resources
      • Office of Inspector General
      • Audits
      • OSHA
    • AAOE Membership
      • Join AAOE
      • Membership Benefits
      • Renew/Pay Dues
    • About AAOE
      • AAOE Board of Directors
      • AAOE Content Committee
      • Volunteer Opportunities
  • For Public & Patients
    • Eye Health A-Z
    • Symptoms
    • Glasses & Contacts
    • Tips & Prevention
    • News
    • Ask an Ophthalmologist
    • Patient Stories
    • No Cost Eye Exams
    • Español
      • A - Z de Salud Ocular
      • Síntomas
      • Anteojos y Lentes de Contacto
      • Consejos y Prevención
      • Noticias
      • Relatos de Pacientes
      • Exámenes de la vista sin costo
      • English
  • AAO 2022
    • Meeting Information
      • Past and Future Meetings
      • Mobile Meeting Guide
      • Contact Information
      • Annual Meeting News
      • Health and Safety
      • Policies and Disclaimers
    • Program
      • Program Highlights
      • Subspecialty Day
      • Virtual Meeting
      • Program Committees
      • CME
      • Meeting Archives
    • Expo
    • Registration
    • Hotels & Travel
      • Hotel Reservation Information
      • Chicago
      • International Attendees
      • Hotel Meeting Space
    • Presenter Central
      • Presenter Central
      • Abstract Selection Process
      • Submission Policies
      • Subject Classification/Topics
      • Instruction Courses and Skills Transfer Labs
      • Papers and Posters
      • Videos
      • Grand Rounds Symposium
      • Program Participant and Faculty Guidelines
      • Faculty Development Program
    • Exhibitors
      • Exhibitor Central
      • Exhibitor Portal Information
      • Exhibitor Prospectus
      • New Exhibiting Companies
      • Exhibitor Resources
      • International Exhibitors
      • Promotional Opportunities
      • Exhibitor Hotel Reservations
  • About
    • Who We Are
      • What We Do
      • About Ophthalmology
      • The Eye Care Team
      • Ethics and the Academy
      • History
      • Museum of Vision
      • Values
    • Governance
      • Council
      • Board of Trustees
      • Committees
      • Academy Past Presidents
      • Secretariats
      • Elections
      • Academy Blog
      • Academy Staff Leadership
    • Leadership Development
    • Awards
      • Laureate Recognition Award
      • Outstanding Advocate Award
      • Outstanding Humanitarian Service Award
      • International Blindness Prevention Award
      • Distinguished Service Award
      • Guests of Honor
      • Secretariat Award
      • Straatsma Award
      • Achievement Award Program
      • Artemis Award
      • EnergEYES Award
      • International Education Award
      • International Scholar Award
      • Commitment to Advocacy Award
      • Visionary Society Award
    • Financial Relationships
    • Policy Statements
    • Related Organizations
      • Subspecialty/Specialized Interest Society Directory
      • State Society Directory
      • Subspecialty/Specialized Interest Society Meetings
      • State Society Meetings
      • Resources for Societies
    • Year in Review
      • 2020 Year in Review
  • Foundation
    • About
      • 2020-2021 Annual Report
      • Annual Report Archives
      • News From the Chair
      • Foundation Staff
    • Our Impact
      • Partners for Sight
      • Donor Spotlights
      • Global Ophthalmic Community
      • Sponsorships
      • Patients and the Public
    • Giving Options
      • Our Supporters
      • Estate and Planned Giving
      • Ophthalmic Business Council
      • Parke Center Campaign
      • Minority Ophthalmology Mentoring Campaign
      • Museum of the Eye Campaign
    • Orbital Gala
      • Why Attend
      • Photo Recap
      • Corporate Support Opportunities
      • Tribute Gifts
      • Silent Auction
      • Corporate Sponsors
    • Donate
    • Museum of the Eye Campaign
      • Museum Supporters
  • Museum of the Eye
    • Visit
    • What's On
      • Museum Galleries
      • Special Exhibitions
      • Current Events
      • Past Events
    • Explore
      • Research and Resources
      • Collection Search
      • Previous Exhibits
      • Oral Histories
      • Biographies
    • Volunteer
    • Mailing List
    • Donate
    • About the Museum
      • Museum Blog
  • Young Ophthalmologists
    • YO Info
    • Learn to Bill
    • Engage with the Academy
  • Senior Ophthalmologists
    • Scope
    • Practice Transitions
  • International Ophthalmologists
    • Global Programs and Resources for National Societies
    • Awards
    • Global Outreach
  • Residents
  • Medical Students
×
Shop
Log In Create an Account
  • For Ophthalmologists
  • For Practice Management
  • For Public & Patients
  • Coronavirus
  • About
  • Foundation
  • Museum of the Eye
  • COVID-19
  • Journals
  • Education
    • Education
    • Courses
    • Cases
    • Learning Plans
    • Interactive
    • Focal Points
    • Wills Eye Manual
    • Disease Reviews
    • Clinical Webinars
    • Diagnose This
    • Self-Assessments
    • Education Centers
      • Glaucoma Education Center
      • Pediatric Ophthalmology Education Center
      • Laser Surgery Education Center
      • Oculofacial Plastic Surgery Center
      • Redmond Ethics Center
      • Myopia Resources
      • Thyroid Eye Disease Resources
  • Guidelines
    • Practice Guidelines
    • Preferred Practice Patterns
    • Clinical Statements
    • Ophthalmic Technology Assessments
    • Patient Safety Statements
    • Complementary Therapy Assessments
    • Compendium Guidelines
    • Medical Information Technology
    • Low Vision
    • Choosing Wisely
    • Eye Care for Older Adults
    • Eye Disease Statistics
    • About the Hoskins Center
    • Artificial Intelligence
    • Premium IOLs
    • Patient-Reported Outcomes with LASIK Symptoms and Satisfaction
  • Multimedia
    • Multimedia Library
    • Video
      • 1-Minute Videos
      • Presentations and Lectures
      • Master Class Videos
      • Basic Skills Videos
      • Clinical and Surgical Videos
      • Interviews
      • Resident Lectures
      • Submit a Video
      • YO Video Contest
    • Podcasts
      • Browse Podcast Archive
      • Experts InSight Podcast
      • Ophthalmology Journal Podcast
    • Images
      • Submit an Image
  • News
    • Clinical News
    • Editors' Choice
    • Headlines
    • Current Insight
  • CME
    • CME Central
    • Claim CME Credit and View Transcript
    • CME Planning Resources
    • Complete Your Financial Disclosure
    • Joint Sponsorship Portal
    • LEO Continuing Education Recognition Award
    • Safe ER/LA Opioid Prescribing
    • Check Your Industry Payment Records
  • MOC
  • Residents
    • Resident Education Home
    • Browse All Resident Content
      • Courses
      • Flashcards and Study Presentations
      • Interactive Cases and Simulations
      • Videos
      • Webinars
    • Cataract Master
    • Diversity and Inclusion Education
    • News and Advice from YO Info
    • OKAP and Board Exam Resources
      • OKAP Exam
      • Board Prep Resources
      • OKAP and Board Review Presentations
      • Study Flashcards
    • Pediatric Ophthalmology Education Center
    • PGY-1 and PGY-2 Resources
    • Resident Knowledge Exchange
    • Simulation in Resident Education
    • Clinical Education /
    • Book Excerpts /
    • Basic and Clinical Science Course - Excerpt
  • 2020–2021 BCSC Basic and Clinical Science Course™

    Go to Academy Store Learn more and Purchase.

    8 External Disease and Cornea

    Chapter 10: Infectious Diseases of the External Eye: Microbial and Parasitic Infections

    Microbial and Parasitic Infections of the Eyelid Margin and Conjunctiva

    Bacterial Conjunctivitis in Children and Adults

    PATHOGENESIS

    Overall, 80% of cases of infectious conjunctivitis in adults are viral in origin. While, in children, the number of bacterial conjunctivitis cases is similar to that of viral conjunctivitis cases, bacterial conjunctivitis is much less common than viral conjunctivitis in adults.

    Bacterial conjunctivitis is characterized by bacterial overgrowth and infiltration of the conjunctival epithelial layer and sometimes the substantia propria. The source of infection is either direct contact with an infected individual’s secretions (usually through eye–hand contact) or the spread of infection from the organisms colonizing the patient’s own nasal and sinus mucosa. In an adult with unilateral bacterial conjunctivitis, the nasolacrimal system should be examined, as nasolacrimal duct obstruction, dacryocystitis, or canaliculitis may be the underlying cause.

    Though usually self-limited, bacterial conjunctivitis can occasionally be severe and sight-threatening when caused by virulent bacterial species such as N gonorrhoeae or Streptococcus pyogenes. In rare cases, it may presage life-threatening systemic disease, as with conjunctivitis caused by N meningitidis.

    CLINICAL PRESENTATION

    Bacterial conjunctivitis should be suspected in patients with conjunctival inflammation and a purulent discharge. The rapidity of onset and severity of conjunctival inflammation and discharge are suggestive of the possible causative organism. Table 10-3 outlines the clinical classification of bacterial conjunctivitis based on these parameters.

    Acute purulent conjunctivitis

    PATHOGENESIS

    Acute purulent conjunctivitis is a self-limited infection of the conjunctiva characterized by an acute inflammatory response with purulent discharge of less than 3 weeks’ duration (definition of acute). Cases may occur spontaneously or in epidemics. The most common etiologic pathogens are S pneumoniae, Streptococcus viridans, H influenzae, and S aureus, with the relative frequency of each varying depending on patient age and geographic location.

    CLINICAL PRESENTATION

    Streptococcus pneumoniae conjunctivitis is characterized by a moderate purulent discharge, eyelid edema, chemosis, conjunctival hemorrhages, and occasional inflammatory membranes on the tarsal conjunctiva. Corneal ulceration occurs in rare instances.

    Haemophilus influenzae conjunctivitis occurs in young children, sometimes in association with otitis media, and in adults, particularly those chronically colonized with H influenzae (eg, smokers or patients with chronic bronchopulmonary disease). Acute purulent conjunctivitis caused by H influenzae biotype III (formerly Haemophilus aegyptius) resembles that caused by S pneumoniae; however, conjunctival membranes do not develop, and peripheral corneal epithelial ulcers and stromal infiltrates occur more commonly. H influenzae preseptal cellulitis may be associated with fulminant Haemophilus meningitis, in which up to 20% of patients who recover have long-term neurologic sequelae. The incidence of infection has been reduced by a vigorous program of vaccination against Hib.

    Staphylococcus aureus may produce an acute blepharoconjunctivitis. The discharge tends to be somewhat less purulent than that seen in pneumococcal conjunctivitis, and the associated signs are generally less severe.

    Table 10-3 Clinical Classification of Bacterial Conjunctivitis

    LABORATORY EVALUATION

    Gram-stained smears and culture of the conjunctiva are usually not necessary in uncomplicated, largely self-limited cases of suspected bacterial conjunctivitis but should be used for the following:

    • certain compromised hosts, such as neonates or debilitated or immunocompromised individuals, to assess the risk of local and systemic complications

    • severe cases of purulent conjunctivitis, to differentiate it from hyperpurulent conjunctivitis, which generally requires systemic therapy

    • cases unresponsive to initial therapy

    MANAGEMENT

    Most cases of acute bacterial conjunctivitis resolve in 2–7 days without treatment. Some prospective studies suggest that delaying treatment until day 3 or 4 would significantly reduce the unnecessary use of antibiotics without affecting outcomes. Initiating treatment at this time only for persistent or worsening signs would generally shorten the course and improve symptoms. If the conjunctivitis is improving on day 4, antibiotics may not be necessary at all, as these studies also indicate that initiation of antibiotics after day 4 provides limited benefit. Cases likely to represent a viral conjunctivitis should not be routinely treated with empiric antibiotics.

    When the physician believes that further intervention is indicated, the initial treatment should be weighted toward the results of the Gram-stained morphology of the bacteria identified on the conjunctival smear. Definitive treatment should be based on the culture results, if available, as smear results may sometimes be inconclusive as to the predominant category of organism responsible for the infection. Cultures of the nose or throat may be obtained if an associated sinusitis or pharyngitis is present. Even if no overt sinusitis, rhinitis, or pharyngitis is present, nasal or throat swabs should be considered in cases of relapsing conjunctivitis, because organisms persisting in and colonizing the respiratory tract mucosa may be the source of infection.

    Empiric therapy with polymyxin B-trimethoprim, aminoglycoside or fluoroquinolone drops, or bacitracin or ciprofloxacin ointment can be initiated before results of the Gram stain or culture have been received. The dosing schedule is 4–6 times daily for approximately 5–7 days unless otherwise indicated. Cases with gram-negative coccobacilli on Gram-stained smears are probably caused by Haemophilus species and should be treated with polymyxin B-trimethoprim. Supplemental oral antibiotics are recommended for patients with acute purulent conjunctivitis associated with pharyngitis, for those with conjunctivitis-otitis syndrome, and for children with Haemophilus conjunctivitis.

    Hyperacute gonococcal conjunctivitis

    PATHOGENESIS

    Gonococcal conjunctivitis presents with explosive onset and very rapid progression of severe purulent conjunctivitis: massive exudation; severe chemosis; eyelid edema; marked conjunctival hyperemia; and, in untreated cases, corneal infiltrates, melting, and perforation. The organism most commonly responsible for hyperpurulent conjunctivitis is N gonorrhoeae (Fig 10-11). Gonococcal conjunctivitis is a sexually transmitted disease resulting from direct transmission of the organism, for example, from the genitalia to the hands and then to the eyes or from the mother to the neonate during vaginal delivery.

    CLINICAL PRESENTATION

    Gonococcal conjunctivitis is one of the few bacterial diseases associated with preauricular lymphadenopathy and the formation of conjunctival membranes. Keratitis, the principal cause of sight-threatening complications, has been reported to occur in 15%–40% of cases. Corneal involvement may consist of diffuse epithelial haze, epithelial defects, marginal infiltrates, and ulcerative keratitis that can rapidly progress to perforation.

    LABORATORY EVALUATION

    Neisseria gonorrhoeae grows well on chocolate agar and Thayer-Martin media.

    Figure 10-11 Peripheral corneal ulceration and perforation occurring several days after onset of hyperacute conjunctivitis caused by N gonorrhoeae.

    MANAGEMENT

    Gonococcal conjunctivitis requires systemic antibiotic therapy, with topical ophthalmic antibiotics used as adjunctive therapy only. Current treatment regimens for gonococcal conjunctivitis reflect the increasing prevalence of penicillin-resistant N gonorrhoeae (PRNG) in the United States. Ceftriaxone, a third-generation cephalosporin, is highly effective against PRNG. Patients with gonococcal conjunctivitis without corneal ulceration may be treated on an outpatient basis with 1 intramuscular (IM) ceftriaxone (1 g) injection; patients with corneal ulceration should be admitted to the hospital and treated with intravenous (IV) ceftriaxone (1 g IV every 12 hours) for 3 consecutive days. Patients with penicillin allergy can be given spectinomycin (2 g IM) or oral fluoroquinolones (ciprofloxacin 500 mg or ofloxacin 400 mg orally twice daily for 5 days). When possible, fluoroquinolones should be avoided in children because of potential adverse effects on joint cartilage.

    Erythromycin ointment, bacitracin ointment, gentamicin ointment, and ciprofloxacin solution have been recommended for topical therapy. Treatment of severe cases should include copious, frequent (every 30–60 minutes) irrigation of the conjunctival sac with normal saline to remove inflammatory cells, proteases, and debris that may be toxic to the ocular surface and contribute to corneal melting.

    Up to one-third of patients with gonococcal conjunctivitis have been reported to have concurrent chlamydial venereal disease. Because of this frequent association, it is advisable to give patients supplemental oral antibiotics for treatment of chlamydial infection. Treatment regimens for chlamydia are discussed later in this chapter. Patients should be instructed to refer their sex partners for evaluation and treatment. Other sexually transmitted pathogens causing conjunctivitis include Chlamydia trachomatis, Treponema pallidum, human immunodeficiency virus, and herpes simplex virus (Table 10-4). For further discussion of syphilis, see BCSC Section 1, Update on General Medicine, and Section 9, Uveitis and Ocular Inflammation.

    American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern Guidelines. Conjunctivitis. San Francisco: American Academy of Ophthalmology; 2013. Available at www.aao.org/ppp.

    Table 10-4 Sexually Transmitted Pathogens Associated With Conjunctivitis

    Cortina MS, Tu EY. Antibiotic use in corneal and external eye infections. Focal Points: Clinical Modules for Ophthalmologists. San Francisco: American Academy of Ophthalmology; 2011, module 6.

    Chlamydial conjunctivitis

    PATHOGENESIS

    The bacterium C trachomatis causes several different conjunctivitis syndromes; each is associated with different serotypes of C trachomatis:

    • trachoma: serotypes A–C

    • adult and neonatal inclusion conjunctivitis: serotypes D–K

    • lymphogranuloma venereum: serotypes L1, L2, and L3

    There have been reports of rare cases of keratoconjunctivitis in humans caused by Chlamydia species that typically infect animals, such as Chlamydophila psittaci (formerly Chlamydia psittaci), an agent generally associated with disease in parrots, and the feline pneumonitis agent.

    LABORATORY EVALUATION

    As an obligate intracellular pathogen, C trachomatis cannot be easily isolated using standard ophthalmic culture techniques, requiring either direct observation of the intracellular bacterium or cell culture. Direct visualization is possible with a Giemsa stain or direct fluorescent antibody staining. PCR probes are available and increasingly being used in place of other diagnostic methods.

    CLINICAL PRESENTATION AND MANAGEMENT

    Trachoma and adult inclusion conjunctivitis are discussed individually in the following sections.

    Trachoma

    Trachoma is an infectious disease that occurs in communities with poor hygiene and inadequate sanitation. It affects approximately 150 million individuals worldwide and is the leading cause of preventable blindness. Trachoma is currently endemic in the Middle East and in developing regions around the world. In the United States, it occurs sporadically among American Indians and in mountainous areas of the South. Most infections are transmitted from eye to eye. Transmission may also occur by flies and household fomites, which spread other bacteria as well, causing secondary bacterial infections in patients with trachoma.

    Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med. 2004;351(19):1962–1971.

    CLINICAL PRESENTATION

    The initial symptoms of trachoma include foreign-body sensation, redness, tearing, and mucopurulent discharge. A severe follicular reaction develops, most prominently in the superior tarsal conjunctiva, but sometimes in the superior and inferior fornices, inferior tarsal conjunctiva, semilunar fold, and limbus. In acute trachoma, follicles on the superior tarsus may be obscured by diffuse papillary hypertrophy and inflammatory cell infiltration. Large tarsal follicles in trachoma may become necrotic and eventually heal with significant scarring. Linear or stellate scarring of the superior tarsus (Arlt line) typically occurs (Fig 10-12). Involution and necrosis of follicles may result in limbal depressions known as Herbert pits (Fig 10-13). Corneal findings in trachoma include epithelial keratitis, focal and multifocal peripheral and central stromal infiltrates, and a superficial fibrovascular pannus, which is most prominent in the superior third of the cornea but may extend centrally into the visual axis (Fig 10-14).

    Figure 10-12 Linear scarring of the superior tarsal conjunctiva (Arlt line, white arrows) in a patient with old trachoma with subconjunctival fibrosis (black arrow).

    (Courtesy of Vincent P. deLuise, MD.)

    Figure 10-13 Trachoma exhibiting Herbert pits (arrows) of the superior limbus (round to oval, pigmented areas within pannus).

    (Courtesy of Tom Lietman, MD.)

    Clinical diagnosis of trachoma requires at least 2 of the following clinical features:

    • follicles on the upper tarsal conjunctiva

    • limbal follicles and their sequelae (Herbert pits)

    • typical tarsal conjunctival scarring

    • vascular pannus most marked on the superior limbus

    Severe conjunctival and lacrimal gland duct scarring from chronic trachoma can result in aqueous tear deficiency, tear drainage obstruction, trichiasis, and entropion.

    The World Health Organization (WHO) devised a simple severity-grading system for trachoma based on the presence or absence of 5 key signs:

    1. follicular conjunctival inflammation

    2. diffuse conjunctival inflammation

    3. tarsal conjunctival scarring

    4. aberrant lashes

    5. corneal opacification

    The WHO grading system was developed for use by trained personnel other than ophthalmologists to assess the prevalence and severity of trachoma in population-based surveys in endemic areas.

    Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477–483.

    MANAGEMENT

    Current recommendations for treatment of active trachoma are tetracycline 1% ophthalmic ointment, applied twice daily for 2 months, and oral azithromycin 1000 mg, given as a single dose. Although azithromycin is more effective and easier for patient adherence, cost and availability dictate the best therapy. Topical erythromycin, given at the same frequency as topical tetracycline, and oral tetracycline 1.5–2.0 g daily in divided doses for 3 weeks are also effective. Oral erythromycin is recommended for treatment of rare tetracycline-resistant cases. Management of the vision-threatening complications of trachoma may include tear substitutes for dry eye and eyelid surgery for entropion or trichiasis.

    Figure 10-14 Superior micropannus in a patient with adult chlamydial conjunctivitis (trachoma).

    Adult chlamydial conjunctivitis

    Adult chlamydial conjunctivitis is a sexually transmitted disease often found in conjunction with chlamydial urethritis or cervicitis. It is most prevalent in sexually active adolescents and young adults. Chlamydia is a systemic disease. The eye is usually infected by direct or indirect contact with infected genital secretions, but other modes of transmission may include shared eye cosmetics and inadequately chlorinated swimming pools. Onset of conjunctivitis is typically 1–2 weeks after ocular inoculation and is not as acute as with adenoviral keratoconjunctivitis. Often patients may report having had mild symptoms for weeks to months.

    CLINICAL PRESENTATION

    External signs of adult inclusion conjunctivitis include a follicular conjunctival response that is most prominent in the lower palpebral conjunctiva and fornix, scant mucopurulent discharge, and palpable preauricular adenopathy. Follicles in the bulbar conjunctiva and semilunar fold are frequently present, and these are a helpful and specific sign in patients not using topical medications associated with the finding. Unlike with neonatal forms, inflammatory conjunctival membranes do not develop in adult chlamydial keratoconjunctivitis.

    Corneal involvement may consist of fine or coarse epithelial infiltrates, occasionally associated with subepithelial infiltrates. The keratitis is more likely to be found in the superior cornea but may also occur centrally and resemble adenoviral keratitis. A micropannus, usually extending less than 3 mm from the superior cornea, may develop.

    MANAGEMENT

    Left untreated, adult chlamydial conjunctivitis often resolves spontaneously in 6–18 months. Currently, one of the following oral antibiotic regimens is recommended:

    • azithromycin 1000 mg single dose

    • doxycycline 100 mg twice daily for 7 days

    • tetracycline 250 mg 4 times daily for 7 days

    • erythromycin 500 mg 4 times daily for 7 days

    Patients with laboratory-confirmed chlamydial conjunctivitis and their sexual contacts should be evaluated for coinfection with other sexually transmitted diseases, such as syphilis or gonorrhea, before antibiotic treatment is started. Sexual partners should be concomitantly treated to avoid reinfection.

    Centers for Disease Control and Prevention; Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep. 2006;55(RR-11):1–94.

    Bacterial conjunctivitis in neonates

    Neisseria gonorrhoeae causes the most severe neonatal conjunctivitis. (Neonatal is defined as occurring within the first month of life.) In order of decreasing prevalence, the causes of neonatal bacterial conjunctivitis, reflective of the vaginal and nosocomial flora, are as follows (see Table 10-3):

    • C trachomatis

    • S viridans

    • S aureus

    • H influenzae

    • group D Streptococcus

    • Moraxella catarrhalis

    • E coli and other gram-negative rods

    • N gonorrhoeae

    Ophthalmia neonatorum is discussed in more detail in BCSC Section 6, Pediatric Ophthalmology and Strabismus.

    Neonatal gonococcal conjunctivitis

    Prenatal screening for maternal gonococcal genital infection and neonatal antibiotic prophylaxis have reduced the overall rate of neonatal gonococcal conjunctivitis, a bilateral conjunctival discharge that typically develops 3–5 days after parturition. The discharge may be serosanguineous during the first several days, with a copious purulent exudate, severe corneal complications, and endophthalmitis developing later (see “Hyperacute gonococcal conjunctivitis” earlier in the chapter). Infected infants may also have other localized gonococcal infections, including rhinitis and proctitis. Disseminated gonococcal infection with arthritis, meningitis, pneumonia, and sepsis resulting in death of the infant is a rare complication.

    MANAGEMENT

    Because of the developing resistance of N gonorrhoeae to various antibiotics— including penicillin (PRNG), fluoroquinolones (QRNG), and tetracycline—the currently recommended first-line treatment for neonatal gonococcal conjunctivitis is ceftriaxone. For nondisseminated infections, a single IM or IV ceftriaxone injection (up to 125 mg or a dose of 25–50 mg/kg) or cefotaxime at a single dose of 100 mg/kg IV or IM is recommended. For disseminated infection, treatment should be augmented according to consultation with a specialist in infectious diseases. Either of these regimens should be combined with hourly saline irrigation of the conjunctiva until discharge is eliminated. If corneal involvement is suspected, application of topical erythromycin or gentamicin ointment or frequent application of a topical fluoroquinolone should be considered. Topical cycloplegia may also prove beneficial. Systemic treatment is advised for infants born to mothers with active gonorrhea, even in the absence of conjunctivitis.

    American Academy of Pediatrics. Gonococcal infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. 2009 Red Book: Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:305–313.

    Centers for Disease Control and Prevention; Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep. 2006;55(RR-11): 1–94.

    Cortina MS, Tu EY. Antibiotic use in corneal and external eye infections. Focal Points: Clinical Modules for Ophthalmologists. San Francisco: American Academy of Ophthalmology; 2011, module 6.

    Neonatal chlamydial conjunctivitis

    Chlamydial conjunctivitis in neonates differs clinically from that in adults in the following ways:

    • There is no follicular response in newborns.

    • The amount of mucopurulent discharge is greater in newborns.

    • Pseudomembranes can develop on the tarsal conjunctiva in newborns.

    • Intracytoplasmic inclusions are seen in a greater percentage of Giemsa-stained conjunctival specimens in newborns.

    • The infection in newborns is more likely to respond to topical medications.

    Both Gram and Giemsa stains of conjunctival scrapings are recommended in neonates with conjunctivitis to identify C trachomatis and N gonorrhoeae, as well as other bacteria, as causative agents. Other Chlamydia-associated infections, such as pneumonitis and otitis media, can accompany inclusion conjunctivitis in the newborn. Therefore, systemic erythromycin (12.5 mg/kg oral or IV 4 times daily for 14 days) is recommended, even though inclusion conjunctivitis in the newborn usually responds to topical erythromycin or sulfacetamide.

    Excerpted from BCSC 2020-2021 series: Section 10 - Glaucoma. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.

  • Most Commented
    Loading, please wait...
    There are no comments available.
    Most Viewed
    Loading, please wait...
    Most Viewed content is not available.
  • The Academy Store
    2022-2023 Basic and Clinical Science Course, Complete Print Set
    2022-2023 Basic and Clinical Science Course, Complete eBook Set
    2022-2023 Basic and Clinical Science Course, Complete Print and eBook Set
    2022-2023 Basic and Clinical Science Course, Residency Print Set
    2022-2023 Basic and Clinical Science Course, Residency eBook Set
    2022-2023 Basic and Clinical Science Course Complete Set
    2022-2023 Basic and Clinical Science Course Residency Set
    2022-2023 Basic and Clinical Science Course, Section 01: Update on General Medicine
    2022-2023 Basic and Clinical Science Course, Section 02: Fundamentals and Principles of Ophthalmology
    2022-2023 Basic and Clinical Science Course, Section 03: Clinical Optics and Vision Rehabilitation
    2022-2023 Basic and Clinical Science Course, Section 04: Ophthalmic Pathology and Intraocular Tumors
    2022-2023 Basic and Clinical Science Course, Section 05: Neuro-Ophthalmology
    2022-2023 Basic and Clinical Science Course, Section 06: Pediatric Ophthalmology and Strabismus
    2022-2023 Basic and Clinical Science Course, Section 07: Oculofacial Plastic and Orbital Surgery
    2022-2023 Basic and Clinical Science Course, Section 08: External Disease and Cornea
    2022-2023 Basic and Clinical Science Course, Section 09: Uveitis and Ocular Inflammation
    2022-2023 Basic and Clinical Science Course, Section 10: Glaucoma
    2022-2023 Basic and Clinical Science Course, Section 11: Lens and Cataract
    2022-2023 Basic and Clinical Science Course, Section 12: Retina and Vitreous
    2022-2023 Basic and Clinical Science Course, Section 13: Refractive Surgery
    The Technician Point System: How to Improve Practice Accountability and Bottom Line (Free Member Webinar)
    Transitioning Your Practice: Retiring, Selling or Buying a Practice (Free Member Webinar)
    How to Build a Patient-First Culture (Free Member Webinar)
    2022 IRIS Registry (Intelligent Research in Sight) Preparation Kit
    Advances in Medical and Surgical Management: The 2022 Update on Glaucoma
    Presbyopia-Correcting IOLs
    2022 Codequest - Multistate (Recorded March 29)
    2022 Codequest Virtual (Multistate)
    Retina Patient Education Video Collection
    Cataract and Refractive Surgery Patient Education Video Collection
 
  • Contact Us
  • About the Academy
  • Jobs at the Academy
  • Financial Relationships with Industry
  • Medical Disclaimer
  • Privacy Policy
  • Terms of Service
  • Help
  • For Advertisers
  • For Media
  • Ophthalmology Job Center

OUR SITES

  • EyeWiki
  • International Society of Refractive Surgery

FOLLOW THE ACADEMY

Medical Professionals

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

Public & Patients

  • Facebook
  • Twitter
  • Instagram
  • YouTube

Museum of the Eye

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Trip Advisor
  • Yelp
© American Academy of Ophthalmology 2022